rs4462937
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001366028.2(DNAH12):āc.5179T>Cā(p.Tyr1727His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.249 in 1,550,806 control chromosomes in the GnomAD database, including 51,843 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_001366028.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAH12 | NM_001366028.2 | c.5179T>C | p.Tyr1727His | missense_variant | 34/74 | ENST00000495027.6 | NP_001352957.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAH12 | ENST00000495027.6 | c.5179T>C | p.Tyr1727His | missense_variant | 34/74 | 5 | NM_001366028.2 | ENSP00000418137 | P1 | |
DNAH12 | ENST00000351747.6 | c.5110T>C | p.Tyr1704His | missense_variant | 34/59 | 5 | ENSP00000295937 |
Frequencies
GnomAD3 genomes AF: 0.240 AC: 36416AN: 152006Hom.: 4955 Cov.: 32
GnomAD3 exomes AF: 0.300 AC: 45963AN: 153290Hom.: 7457 AF XY: 0.306 AC XY: 24912AN XY: 81314
GnomAD4 exome AF: 0.250 AC: 349419AN: 1398680Hom.: 46886 Cov.: 36 AF XY: 0.255 AC XY: 176028AN XY: 689778
GnomAD4 genome AF: 0.239 AC: 36428AN: 152126Hom.: 4957 Cov.: 32 AF XY: 0.250 AC XY: 18568AN XY: 74348
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at